Page 17 - Ipo Gmp

Nephrocare Health IPO opens; here's all you should know before applying

Here are the key details of the Nephrocare Health Services IPO that every investor should be aware of before placing bids for the public offering

Nephrocare Health IPO opens Dec 10: Should you bid? Here's what experts say

Nephrocare Health IPO comprises a fresh issue of 7.7 million, amounting to ₹353.4 crore and an offer for sale (OFS) of 11.3 million equity shares amounting to ₹517.64 crore

Park Medi World IPO: Analysts split on prospects; should you apply?

The three-day subscription window to bid for the Park Medi World IPO will close on Friday, December 12, 2025

Aequs IPO listing on December 10: Here's what latest GMP indicates

Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent

Meesho IPO to make D-St debut on Dec 10: Here's what latest GMP hints at

Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer

Investing in Nephrocare Health IPO? Check 5 key risks before you decide

Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares

Park Medi World IPO opens Dec 10: GMP at 20%; 5 key risks you should know

The unlisted shares of Park Medi World were trading at ₹193 in the grey market, commanding a premium of ₹33 or 20 per cent from the upper end price of ₹162

Corona Remedies IPO off to a lukewarm start; GMP holds steady at 27%

Corona Remedies IPO: Check price band, lot size GMP, subscription status, reviews, and other key details here

Subscribed to Aequs IPO? Here's how to check allotment status, latest GMP

Once the allotment is finalised, investors who applied for the public offering can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue

Wakefit Innovations IPO opens today: Check GMP, price band, dates, review

Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5

Meesho IPO subscribed 79x; check allotment status, GMP, listing date

Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies

Last day to bid for Vidya Wires IPO: Check subscription status, GMP

Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Final hours! Heavy NII, retail bidding boosts Meesho IPO; GMP holds steady

Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Retail investors drive demand for Aequs IPO on Day 1, NIIs follow; QIBs lag

Retail investors have oversubscribed their reserved portion by 6.42 times, while non-institutional investors (NIIs) have closely followed, with their segment oversubscribed by 1.45 times

Vidya Wires IPO fully subscribed: Retail investors lead demand; GMP at 12%

Vidya Wires IPO Day 1 update: Retail individual investors (RIIs) led the response, subscribing to their allocated portion 1.86 times

Corona Remedies IPO price band at ₹1,008-1,062; check dates, GMP, objective

Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares

Meesho IPO opens: From price band to GMP, here's all you need to know

Meesho IPO opens today: Check price band, lot size, GMP, review, allotment date, listing date and other key details here